Tag: Crohn’s diagnosis
New Crohn’s Drug Shows Promise: What Mirikizumab Could Mean
New clinical trial results show mirikizumab helped over half of treatment-resistant Crohn’s patients achieve remission, with participants reporting improved quality of life and restored energy. This experimental drug represents promising progress in targeted IBD therapy.
New Crohn’s Treatment Shows Promise: What Obefazimod Could Mean
New research on obefazimod shows promising results for people with moderate to severe Crohn’s disease, with encouraging rates of clinical remission and improved quality of life. While still in clinical trials, this development offers hope for better treatment options ahead.
Ultraprocessed Grains May Increase IBD Risk: Research Findings
New European research following over 100,000 adults found that high consumption of ultraprocessed grains may increase IBD risk. This finding remained significant even after accounting for other dietary and lifestyle factors, offering important insights for the IBD community about food processing and gut health.
New Research on Gut Chemical Succinate Could Change Crohn’s Treatment
New research reveals that succinate, a naturally occurring gut chemical, may drive inflammation in Crohn’s disease. This discovery could lead to targeted treatments that rebalance gut chemistry rather than broadly suppressing the immune system.
New Hope on the Horizon: IBD Treatment Options Are Expanding
Recent research shows the IBD and IBS treatment market is experiencing significant growth, driven by better diagnostics, increased awareness, and substantial investment in new therapies. This expansion could mean more personalized treatment options and improved quality of life for people living with inflammatory bowel disease.
Plant-Based Eating May Lower IBD Risk – But Quality Matters
New research suggests healthy plant-based diets rich in whole foods may help protect against IBD development. However, the quality of plant foods matters more than simply avoiding animal products, with processed plant foods offering no protective benefits.
New Hope for Kids with Crohn’s: Breakthrough Study Results
AbbVie’s new pediatric Crohn’s study shows promising results for children with moderate to severe disease who haven’t responded to other treatments. The research offers hope for fewer symptoms and better remission maintenance in young patients.
Ustekinumab vs Vedolizumab: Real Hope for Better Crohn’s Control
New real-world research comparing ustekinumab and vedolizumab shows promising results for Crohn’s patients. We break down what this means for your treatment decisions and conversations with your doctor.
Managing Social Media During IBD Flares: Your Mental Health Matters
Struggling with whether to share your IBD journey online during flares? You’re not alone in feeling torn between staying connected and protecting your mental health. Here’s why both choices are valid and how to decide what works best for you.
Palisade Bio’s Financial Update: What IBD Patients Need to Know
Palisade Bio’s latest financial report reveals steady progress in IBD treatment development, with successful fundraising supporting ongoing clinical programs. Understanding what these financial milestones mean can help patients gauge the future treatment landscape.
